Simply Wall St.
3 Growth Companies With High Insider Ownership Achieving 29% Revenue Growth
📈
AI Sentiment
Highly Positive
8/10
- Home
- TLSI
as of 12-15-2025 3:54pm EST
$7.29
$0.01
-0.21%
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
Chart Type:
Time Range:
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | WESTMINSTER |
| Market Cap: | 244.3M | IPO Year: | N/A |
| Target Price: | $10.67 | AVG Volume (30 days): | 175.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.14 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.42 - $7.70 | Next Earning Date: | 11-13-2025 |
| Revenue: | $40,207,000 | Revenue Growth: | 49.52% |
| Revenue Growth (this year): | 55.06% | Revenue Growth (next year): | 46.04% |
AI-Powered TLSI Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 70.00%
70.00%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest TriSalus Life Sciences Inc. News
TLSI Breaking Stock News: Dive into TLSI Ticker-Specific Updates for Smart Investing
Compare TLSI vs Leading Stocks
See how TLSI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TLSI TriSalus Life Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.